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ABSTRACT 
 
GREEN COFFEE BEAN EXTRACT REDUCES FAT ACCUMULATION  
IN DROSOPHILA MELANOGASTER 
 
MAY 2020 
 
LYNNEA YOUNG, B.S., UNIVERSITY OF MASSACHUSETTS, AMHERST, MA, USA 
 
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST, MA, USA 
 
Directed by: Professor Yeonhwa Park 
 
 With obesity on the rise, there has been great interest in identifying functional foods 
that can alter metabolism to mitigate obesity. One nutraceutical that has gained attention is 
green coffee bean extract (GCBE), sourced from raw coffee beans. Research has shown that 
it has a variety of biological effects including antioxidant and anti-inflammatory properties 
and regulation of lipid and glucose metabolism. It has been reported that the main 
polyphenolic compound in GCBE, chlorogenic acid (CGA), is likely responsible for these 
effects. However, GCBE had not yet been studied in Drosophila melanogaster, the fruit fly. 
Drosophila are a noted model organism as flies and humans share 60% of disease related 
genes and similar mechanisms for metabolic regulation. In this study, flies were treated with 
0, 1, or 2 mg/mL GCBE and physiological parameters and gene expression were assessed. 
GCBE significantly reduced fat accumulation in flies, in part by a reduction in food intake. 
Flies were also treated with an isoform of CGA, 5-caffeoylquinic acid, but this treatment did 
not change fat accumulation. Overall, this study serves as a foundation for further research on 
GCBE to determine its potential mechanism of action. This may inform the use of GCBE as 
a nutraceutical for the treatment of obesity.
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CHAPTER 1 
 
LITERATURE REVIEW: METABOLIC EFFECTS OF GREEN COFFEE BEAN 
EXTRACT 
1.1 Introduction 
 Current trends in health and wellness show that consumers have an increased interest 
in living “naturally”, with foods and drugs derived from whole, particularly, plant-based 
sources. In addition to this trend, obesity and its associated metabolic diseases are on the rise 
(Ogden & Flegal, 2015). In response, researchers have worked to identify therapeutic 
treatments to mitigate obesity. Nutraceuticals, foods or parts of foods that provide health 
benefits beyond basic nutrition, may provide a solution that satisfy the desire for natural 
treatments while helping to decrease levels of obesity in the population. Green coffee bean 
has been noticed for its ability to modulate metabolism and potentially reduce obesity.  
 Green coffee bean extract (GCBE) is derived from the unroasted seed of the coffee 
plant. Without heat processing from roasting, it retains a higher content of polyphenols 
compared to roasted coffee beans that are typically used to make brewed coffee beans. 
Therefore, there has been great interest in assessing the bioactive effects GCBE may 
potentially have. It has been shown that GCBE has beneficial antioxidant and anti-
inflammatory effects and is able to regulate lipid and glucose metabolism.  
 The objective of this review is to summarize the current knowledge on green coffee 
bean and its main active compound, chlorogenic acid (CGA) and their major biological 
actions, specifically in anti-inflammatory, antioxidant, and metabolic regulatory effects.  
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1.2 Green Coffee Bean Extract  
1.2.1 Source 
Coffee is one of the most widely consumed beverages in the world. It’s typically 
brewed from the dried and roasted seeds, known as coffee beans, of the coffee plant (Farah & 
Duarte, 2015). The main varieties are Coffea arabica and Coffea canephora var. robusta. 
However, it is known that the typical method of preparing coffee for consumption, such as 
roasting at high temperature, causes heat degradation of beneficial polyphenolic compounds 
(Şemen et al., 2017). Therefore, much attention has been brought to green unroasted coffee 
beans, because they may serve a better source of polyphenols and have higher antioxidant 
capacity. Green coffee bean extract (GCBE) is produced by softening raw green coffee beans 
and using 6# solvent oil, ethanol, and water extraction and filtration to yield an extract 
powder, with approximately 50% CGA and 12% caffeine content (Cheng et al., 2014). 
GCBE also contains other bioactive compounds, such as theophylline, theobromine, cafestol, 
kahweol, tocopherols and trigonelline (Jeszka-Skowron et al., 2016). 
 
1.2.2 Chlorogenic Acid  
The main polyphenolic compound in GCBE extract is CGA (Fig. 1). CGA refers to a 
family of compounds that are esters of cinnamic and quinic acids, including subgroups of 
mono-, di-, tri-, and tetra-esters of caffeic acid, coumaroylquinic acids and feruloylquinic 
acids, and mixed di-esters of caffeic and ferulic acid (Clifford, 1999).  
In addition, every subgroup of CGA contains several isomeric forms, like 5-O-
caffeoylquinic acid (5-CQA), 4-CQA, 3-CQA, and varying residues of caffeic acid or quinic 
acids generating molecules like caffeoylferuloylquinic acids and caffeoylsinapoylquinic 
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acids. Thus, a sample of GCBE can contain a diverse and vast set of CGA forms. However, 
the most common and commercially available isomer of CGA is 5-CQA. It should be noted 
that after the identity of CGA was determined, the International Union of Pure and Applied 
Chemistry (IUPAC) reversed the ordering of numbering of atoms on the quinic acid ring, so 
that what is 5-CQA now, was formerly known as 3-CQA. Though some literature still uses 
the old convention, this review will refer to the most abundant isomer of CQA as 5-CQA to 
stay consistent with current IUPAC nomenclature and more recent publications.  
 
1.3 Antioxidant and Anti-inflammatory Effects 
 GCBE has antioxidant and anti-inflammatory properties that are attributed to its 
polyphenolic compounds (Lee et al., 2019). With CGA as the main fraction of polyphenols, 
this review will focus primarily on its effects. CGA has antioxidant properties that are 
protective against toxicities and chronic diseases associated with oxidative stress in various 
Figure 1.1 Representative structure of Chlorogenic Acid and Constituent Groups. 
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biological systems (Liang et al., 2016).  CGA’s mechanisms of action include reducing 
generation of free radicals and scavenging free radicals (Zang et al., 2002). It was reported 
that CGA can chelate metals that induce the production of reactive oxygen species (ROS), 
which are the precursors to free radical species, thus, reducing free radical generation (Wang 
et al., 2017). It was further reported that CGA can modulate the antioxidant protein 
transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2) to enhance the body’s 
antioxidant and detoxification response, especially in the liver (Wei et al., 2018). In addition, 
it can improve the activity of antioxidant enzymes like glutathione peroxidase (GSH-Px) and 
catalase (CAT) that break down cellular ROS (J. Chen et al., 2018). In RAW 264.7 cells, 
CGA reduced nitric oxide (NO) production and inhibited inducible NO synthase (iNOS) gene 
expression (Hwang et al., 2014). The same group also showed that CGA reduces the 
expression of pro-inflammatory cytokines and chemokines, including tumor necrosis factor 
alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and cyclooxygenase-2 (COX-
2) by modulating the nuclear factor kappa B (NF-κB) signaling pathway as seen by decreased 
suppression of I kappa beta (IκB) protein in cells with lipopolysaccharide (LPS)-induced 
inflammation (Hwang et al., 2014). The proteasome also has a role in regulation of NF-κB 
and other inflammatory signaling pathways and CGA may modulate inflammation by 
inhibiting proteasome activity (Francisco et al., 2013). Finally, as an orally delivered 
nutraceutical, CGA can reach the large intestine and serve as a substrate for microbial 
fermentation and change the products of the microbiome, including short chain fatty acids 
(SCFA). It was shown that CGA can reduce hepatic inflammation through modulation of 
SCFA because of their involvement in anti-inflammatory response pathways (Nishitsuji et 
al., 2018). 
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1.4 Effects on Obesity and Metabolic Syndrome 
Much research has been conducted regarding the anti-obesity effects of GCBE, with 
the effects being attributed to its constituent polyphenolic compounds like CGA. GCBE can 
significantly reduce fat accumulation in animal models (Choi et al., 2016; Farias-Pereira et 
al., 2018; Li Kwok Cheong et al., 2014; Shimoda et al., 2006). Farias-Pereira et al. 
investigated GCBE in Caenorhabditis elegans, a model organism with conserved fat and 
energy regulation pathways. The study compared the effects of whole GCBE and 5-CQA to 
assess the mechanism of action of GCBE. It was suggested that GCBE and 5-CQA were 
involved in pathways related to lipogenesis, energy homeostasis, and lipid uptake. In 
mammalian models, GCBE reduced body weight, visceral fat accumulation, insulin 
resistance, and altered lipid profiles by modulating genes related to fatty acid oxidation, 
energy homeostasis, adipocyte differentiation, and glucose metabolism (Choi et al., 2016; Li 
Kwok Cheong et al., 2014; Shimoda et al., 2006). There is a general agreement that 
polyphenolic compounds like CGA are responsible for the beneficial biological effects of 
taking GCBE. 
 
1.5 Role of Chlorogenic Acid 
The main effect of GCBE is thought to be caused by CGA’s modulation of lipid and 
glucose metabolism. CGA has been shown to decrease triglyceride (TG) and free fatty acid 
(FFA) levels in the liver and plasma by regulating acetyl CoA carboxylase (ACC) and 
carnitine palmitoyltransferase 1 (CPT-1), enzymes involved in FFA oxidation and synthesis, 
respectively (Sudeep et al., 2016). Another critical target for CGA is AMP-activated protein 
6 
 
kinase (AMPK). CGA activates AMPK, which improved lipid and glucose profiles, 
mitigated hepatic steatosis, and dyslipidemia in Leprdb/db mice model (Ong et al., 2013).  
 
1.5.1 Adiponectin and Leptin Ratio 
 CGA can moderate adiponectin/leptin ratio in high-fat fed mice by elevating plasma 
adiponectin levels (Cho et al., 2010). As obesity can be also characterized by increased 
circulating leptin paired with decrease in adiponectin (Frühbeck et al., 2017), the balance of 
these 2 adipokines are considered a marker of adipose tissue dysfunction (Vega & Grundy, 
2013). More adiponectin can increase activation of peroxisome proliferator-activated 
receptor (PPAR-α), which may reduce TG by increasing fatty acid oxidation and energy 
consumption.  
 
1.5.2 Regulation of AMPK 
 Regulation of AMPK also plays a significant role in CGA’s ability to regulate 
glucose metabolism and mitigate diabetes. First, it can stimulate glucose uptake in skeletal 
muscle through the activation of AMPK (Ong et al., 2012). The long-term consumption of 
CGA can affect other metabolic pathways downstream of AMPK phosphorylation. Through 
activation of AMPK, CGA inhibited hepatic glucose-6-phosphatase expression and activity, 
attenuated hepatic steatosis, and improved lipid profiles, which improved fasting glucose 
levels, glucose tolerance, and insulin sensitivity (Ong et al., 2013). These effects on glucose 
metabolism show that CGA can attenuate the symptoms of type 2 diabetes. However, other 
research disputes these effects; chlorogenic acid did not reverse glucose intolerance in obese   
7 
 
rats even through CGA was able to reverse physical changes in cardiovascular structure, 
including reduced systolic blood pressure and diastolic stiffness (Bhandarkar et al., 2019).  
 
1.5.3 Inconsistent Reports 
There are inconsistent reports on whether CGA has definitive anti-obesity effects. 
One study found that supplementation of coffee extract (CE) containing CGA was able to 
reduce symptoms of metabolic syndrome like glucose intolerance, cardiovascular 
remodeling, and nonalcoholic liver disease without reducing abdominal obesity (Panchal et 
al., 2012). Another found that coffee or its components like caffeine and chlorogenic acid did 
not attenuate body weight or visceral fat in obese mice, but altered the microbiome and 
reduced liver inflammation (Nishitsuji et al., 2018).  
 Overall, CGA found in GCBE is a metabolic affecter that can reduce obesity and 
related disorders caused by metabolic syndrome. Its effects in vivo are complicated and need 
to be studied further to understand its mechanism. CGA is a promising therapy against 
obesity and metabolic disease.  
1.6 Conclusion 
 This review summarizes the published scientific reports on the effects of GCBE and 
CGA in antioxidant and anti-inflammatory function and metabolic regulation. Overall, the 
research suggests that GCBE and CGA exerts these effects through a variety of pathways 
including ROS scavenging and quenching for antioxidant and anti-inflammatory pathways 
and modulation of lipid and glucose metabolism (Fig. 2). GCBE and CGA may be useful in 
the treatment of related disorders and diseases like obesity and metabolic syndrome. 
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Figure 1.2 Summary of GCBE Biological Effects 
ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; CPT, carnitine 
palmitoyl transferase; FAS, fatty acid synthase; FFA, free fatty acid; FOXO, forkhead box O; 
GCBE, green coffee bean extract; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; NO, 
nitric oxide; PPAR, peroxisome proliferator activated receptor; ROS, reactive oxygen 
species; RXR, retinoid X receptor; SREBP, sterol regulatory element-binding protein; TG, 
triglyceride 
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Table 1.1 Summary of in vivo studies of GCBE and CGA on metabolism. 
Material Dosagea Treat-
ment  
Time 
Model Observationsb Suggested 
Mechanismsc 
Referen-
ces 
CGA 2.65 
mg/mL 
3 days C. elegans ↓ TG ↑ ECH4, 
FOXO; 
↓ ACC, 
ACS2, 
FAR4, 
C/EBPα, 
SREBP 
(Farias-
Pereira 
et al., 
2018) 
CGA 0.02% 
of diet 
7 days High fat 
diet fed 
ICR mice 
(♂) 
↓ BW, visceral fat, 
plasma leptin, TG, 
cholesterol; 
↑ adiponectin 
 
↑ PPARα; 
↓ HMGR, 
ACAT 
(Cho et 
al., 
2010) 
CGA 100 
mg/kg 
BW 
6-15 
weeks 
High fat 
diet fed 
C57BL/6J 
mice (♂) 
↓BW, cholesterol, 
FFA, glucose, 
insulin, TG 
↑ ACOX1, 
CPT1, 
PPARα; 
↓ CD36, 
FABP4, 
MGAT, 
PPARγ 
(Ma et 
al., 
2015) 
CGA 250 
mg/kg 
BW 
2 
weeks 
Leprdb/db 
mice (♂) 
↓BW, cholesterol, 
FFA, glucose, 
insulin, TG; 
↑ adiponectin 
↑ AMPK, 
CaMKK; 
↓ ACC 
(Ong et 
al., 
2012) 
CGA 250 
mg/kg 
BW 
2 
weeks 
Leprdb/db 
mice (♂) 
↓BW, cholesterol, 
FFA, glucose, 
insulin, TG; 
↑ adiponectin 
↑ AMPK, 
CaMKK; 
↓ ACC 
(Ong et 
al., 
2012) 
CGA 90 
mg/kg 
BW 
12 
weeks 
High fat 
diet fed 
Sprague–
Dawley 
rats (♂) 
↓BW, visceral 
weight, TG, 
cholesterol, LDL, 
FFA 
↑ PPARα, 
RXRα, 
CPT2; 
↓ LXRα, 
LPL, CD36, 
ACC, FAS 
(K. 
Huang et 
al., 
2015) 
CGA 100 
mg/kg 
BW 
8 
weeks 
High 
fat/carbohy
drate diet 
fed Wistar 
rats (♂) 
↓ visceral fat, 
systolic blood 
pressure, liver 
inflammation and 
fat 
Modulation 
of gut 
microbiota 
(Bhanda
rkar et 
al., 
2019) 
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CGA 150 
mg/kg 
BW 
6 
weeks 
High fat 
diet 
Sprague-
Dawley 
rats (♂) 
↓ BW, cholesterol, 
TG, FFA 
↑ AMPK, 
CPT1; 
↓ ACC 
(Sudeep 
et al., 
2016) 
GCBE 
(50% 
CGA, 
2% 
caffeine) 
5 
mg/mL  
3 days C.elegans ↓ TG ↑ ACS2, 
ECH4, 
FOXO, HSL; 
↓ ACC, 
FAR4, 
SREBP 
(Farias-
Pereira 
et al., 
2018) 
GCBE 
(27% 
CGA, 
10% 
caffeine) 
1 % of 
diet 
2 
weeks 
ddy mice 
(♂) 
↓BW, visceral fat, 
TG 
↑ CPT (Shimod
a et al., 
2006) 
GCBE 
(71% 
CGA, 
0.03% 
caffeine) 
 
0.5% of 
diet 
12 
weeks 
High fat 
diet fed 
C57BL/6J 
mice (♂) 
No effect NA (Li 
Kwok 
Cheong 
et al., 
2014) 
GCBE 
(50% 
CGA) 
200 
mg/kg 
BW 
 
6 
weeks 
C57BL/6J 
mice (♂) 
↓ BW gain, liver 
weight, WAT 
weight 
↑ PPARα, 
ATGL, HSL, 
CPT1 
↓ C/EBPα, 
SREBP-1c, 
SREBP-2, 
PPARγ, FAS 
 
(Choi et 
al., 
2016) 
a. BW, body weight 
b. BW, body weight; TG, triglyceride; FFA, free fatty acid; LDL, low-density lipoprotein; 
WAT, white adipose tissue 
c. ACAT, acyl-CoA cholesterol acyltransferase; ACC, acetyl-CoA carboxylase; ACOX, 
acyl-CoA oxidase; ACS, Acetyl-coenzyme A synthetase; AMPK, AMP-activated protein 
kinase; ATGL, adipose triglyceride lipase; C/EBP, CCAAT/enhancer binding protein; 
CaMKK, calcium/calmodulin-dependent protein kinase kinase; CD, cluster of differentiation; 
CPT, carnitine palmitoyl transferase; ECH, enoyl-CoA hydratase; FABP, fatty acid-binding 
protein; FAR, fatty acid- and retinoid-binding protein; FAS, fatty acid synthase; FOXO, 
forkhead box O; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; HSL, hormone 
sensitive lipase; LPL, lipoprotein lipase; LXR, liver X receptor; MGAT, monoacylglycerol 
acyltransferase; PPAR, peroxisome proliferator activated receptor; RXR, retinoid X receptor; 
SREBP, sterol regulatory element-binding protein 
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CHAPTER 2 
GREEN COFFEE BEAN EXTRACT REDUCES FAT ACCUMULATION IN 
DROSOPHILA MELANOGASTER 
2.1 Introduction 
Obesity has developed into a global health crisis over the past several decades as rates 
have tripled since 1975 (Ogden & Flegal, 2015). Obesity is linked to range of conditions 
including cardiovascular disease, high blood pressure, high blood cholesterol, and type 2 
diabetes mellitus (Must et al., 1999). Obese individuals are also at risk of joint and muscular 
disorders, respiratory problems, and increased cancer mortality (Fruh, 2017). Therefore, it is 
important to find therapeutic interventions beyond typical diet and lifestyle changes. 
Nutraceuticals have garnered attention for their ability to affect metabolism, including 
moderation of obesity (Dulloo, 2011). One nutraceutical that has been identified as having 
potential anti-obesity effects is green coffee, the unroasted seed of the coffee plant. Though 
the roasted form is more typical, green coffee contains more bioactive because the phenolic 
compounds have not been degraded by heat processing (Şemen et al., 2017). The extract of 
green coffee will be investigated in this study.  
Green coffee bean extract (GCBE) and its constituent polyphenolic compound, CGA, 
are both known for their effects in metabolic regulation. GCBE has been shown to reduce fat 
accumulation in animals by modulating genes related to lipogenesis, fatty acid oxidation, 
energy homeostasis, adipocyte differentiation, and glucose metabolism (Choi et al., 2016; 
Farias-Pereira et al., 2018; Li Kwok Cheong et al., 2014; Shimoda et al., 2006). Though there 
has been evidence that describes the effects and mechanisms of GCBE and CGA in rodent 
models, there has not been any investigation of GCBE in Drosophila melanogaster.    
12 
 
D. melanogaster, commonly known as fruit flies, are a well-established in vivo model 
for metabolic studies as they have a high degree of conserved biology and physiology with 
humans including similar lipid and carbohydrate metabolisms (Pandey & Nichols, 2011). 
Flies also have tissues analogous to mammalian pancreas, liver, and adipose tissues, which 
all play a role in metabolic regulation (Trinh & Boulianne, 2013). The fat body is the critical 
organ in maintaining homeostasis in flies—it is equivalent to mammalian liver and adipose 
tissue for its storage and metabolism of fat and carbohydrates and its ability to act as an 
endocrine organ (Gutierrez et al., 2007). The fat body is distributed mainly in the abdomen 
but it also extends into the thorax and head so that it is in contact with the hemolymph for 
facilitating the exchange of metabolites (Hoshizaki, 2012). In addition, over 60% of all 
known human disease-causing genes are conserved in flies (Reiter et al. 2001). Therefore, the 
study of GCBE in Drosophila melanogaster is important as it may provide insight into its 
function that can be applicable to mammalian models and humans.  
2.2 Materials and Methods 
2.2.1 Materials  
GCBE (50% chlorogenic acid and 2% caffeine) was purchased from NuSci Institute 
& Corp. (Batch No. 201511005, Walnut, CA, USA), the chlorogenic acid isoform 5-O-
caffeoylquinic acid (5-CQA, IUPAC numbering, CAS 327-97-9; named previously as 
chlorogenic acid or 3-O-caffeoylquinic acid, pre-IUPAC numbering; Farias-Pereira et al., 
2018) was purchased from Sigma-Aldrich Co. (purity ≥95%, St. Louis, MO, USA), fly stock 
bottles and vials from Genesee Scientific (San Diego, CA), and trehalase from Megazyme 
(Chicago, IL). The Jazz-Mix Drosophila food contained 65% brown sugar, 20% cornmeal, 
11.5% yeast, 2.5% agar, 1.5% sodium propionate, 0.5% benzoic acid, and 0.5% methyl 
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paraben (w/v) (ThermoFisher Scientific Inc., Waltham, MA). Liquid food consisted of 5% 
sucrose and 5% yeast in distilled water (w/v). Capillary tube (5 µl) was from VWR 
International (Radnor, PA). Infinity triglycerides reagent, the bicinchoninic (BCA) protein 
assay reagent and Infinity glucose reagent were purchased from ThermoFisher Scientific Inc. 
(Waltham, MA).  
2.2.2 Fly Rearing and GCBE Treatment 
Flies were maintained at 25 °C in 12-hour light/dark (L/D) cycle in stock bottles with 
Jazz-Mix Drosophila food as the medium. To prepare the experimental diet, 0, 1, or 2 
mg/mL GCBE or 0, 0.5, or 1 mg/mL CGA was directly mixed into the Jazz-Mix food during 
preparation. For the diet treatment, 2-4-day old flies were fed a control diet (0 mg/mL) or a 
diet containing the GCBE or CGA for 5 days. 5 days was chosen based on previous work (P. 
B. Chen et al., 2019).  
2.2.3 Food Intake 
Capillary feeding (CAFE) assay was performed based on Ja et al., 2007. with minor 
modifications. Four flies were placed in each vial with 1% agar solution bedding as a water 
source. After 2 days of habituation with liquid food, experimental and control diets were 
placed into the capillary tube and inserted into in the vials. Food was changed daily, and 
daily food intake was determined by volume (µL) with consideration of daily evaporation, 
measured by volume change in vials without flies.  
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2.2.4 Triglyceride/Protein Assay 
 Triglyceride and protein levels were quantified using a triglyceride (TG) and 
bicinchoninic acid (BCA) assay, respectively. Prior to quantification, Drosophila were 
decapitated and then homogenized in groups of 5 with 500 μL PBS and 0.05% Tween 20. 
Homogenized samples were used for TG and protein quantifications. TG concentrations were 
standardized by protein. Instructions were followed as per guidelines from the manufacturers. 
 
2.2.5 Locomotor Activity 
 Locomotion behavior was monitored using the Drosophila Activity Monitoring 
System 2 (TriKinetics, Waltham, MA) (Chiu et al., 2010). Flies were briefly anesthetized 
with carbon dioxide and loaded individually into the monitoring tubes containing control or 
treatment food containing 1 or 2 mg/mL GCBE. Anesthesia was minimized to less than five 
minutes to avoid potential impacts on motor behavior (Bartholomew et al., 2015). Flies were 
habituated for 2 days before the locomotor assay was started. Spontaneous locomotion was 
measured as total infrared beam block counts for 24 hours. Each interruption of the infrared 
beams was considered a move.  
 
2.2.6 Trehalose/Glucose Assay 
Trehalose, a disaccharide of two glucose monomers, acts as the main circulating 
sugar in the hemolymph of insects (Yasugi et al., 2017). In this assay, trehalose was extracted 
from the fly homogenate and converted to glucose using trehalase. Samples of 5 flies were 
weighed, homogenized in a 0.1 M citrate buffer (pH 5.5), and centrifuged (10,000g for 10 
mi). A sample of the supernatant was taken and digested with trehalase in a citrate buffer 
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with 0.5 mg/ml bovine serum albumin for 2 h at 37°C. The total sugar levels in the flies are 
expressed as glucose and were normalized by whole body protein levels.  
 
2.2.7 Quantitative Reverse Transcription PCR  
Total RNA from flies was extracted with Trizol® according to the manufacturer’s 
instructions. RNA purity was assessed by calculating the 260/280 nm absorption ratio. 
Samples with values greater than 1.7 were used. Reverse transcription was carried out using a 
High Capacity cDNA Reverse Transcription Kit, and quantitative reverse transcription PCR 
(qRT-PCR) was performed on the StepOnePlus Real-Time PCR system (Sun et al. 2016). 
The following primers were used for qRT-PCR: actin-42A (act42A; a reference gene; 
Dm02362162_s1), adipokinetic hormone (akh; Dm01822073_g1), brummer (bmm; 
Dm01805233_m1), spargel (srl; Dm02136710_g1), sterol regulatory element-binding 
protein (srebp; Dm01793855_g1), target of rapamycin (tor; Dm01843300_g1), forkhead box 
sub-group O (foxo; Dm02140207_g1), lipid storage droplet 2 (lsd-2, Dm01838905_m1), 
withered (whd, Dm01812891_g1), and enoyl-CoA hydratase short chain 1 (echs-1; 
Dm01797402_g1). Quantification of the relative transcription level was calculated by the 
original concept of 2-Ct. 
 
2.2.8 Statistical Analysis 
GraphPad Prism6 was used for statistical analysis. Data were analyzed by a two-way 
analysis of variance (two-way ANOVA). The majority of experiments were designed as a 
2×3 factorial arrangement with main effects of sex (female vs. male) and diets (Control, 1 
mg/mL GCBE, and 2 mg/mL GCBE). Food intake was conducted as a 2×2 factorial 
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arrangement with effects of sex and diets (Control vs 2 mg/mL GCBE). P-values less than 
0.05 were considered significant. All data were shown per group for presentation purposes 
only, regardless of the results of the two-way ANOVA. 
 
2.3 Results 
2.3.1 Body Weight 
The body weights of flies were significantly different with sex (P<0.0001) and GCBE 
treatment diet (P=0.0165) without interaction (Fig. 1). As expected, females were 44% 
heavier than males. There were significant differences between the control and 1 mg/mL 
GCBE group (P= 0.0365) and between the control and 2 mg/mL GCBE group (P=0.0261) 
(Figure 1). There were no significant differences between the 1 and 2 mg/mL GCBE groups. 
 
 
Figure 2.1 Body weight. Body weight of D. melanogaster 
fed a 0 (control), 1, or 2 mg/mL GCBE diet for 5 days. 
Values are expressed as mean ± S.E.M. (n=7). GCBE, 
green coffee bean extract. 
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2.3.2 Triglyceride Levels 
There were significant differences in TG levels between sexes (P<0.0001) and diet 
groups (P=0.0003) with the interaction reaching significance (P=0.0610, Figure 2). Flies 
treated with 1 mg/mL and 2 mg/mL GCBE showed a 20% and 24% reduction in TG 
compared to control groups, respectively.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Fat Content. Triglyceride content of D. 
melanogaster fed a 0 (control), 1, or 2 mg/mL GCBE diet 
for 5 days. Values are expressed as mean ± S.E.M. (n=7). 
TG, triglyceride; GCBE, green coffee bean extract. 
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2.3.3 Total Sugar 
There were no significant effects of overall sex or diet on total sugar levels, but there 
was significant  sex-diet interaction (P=0.0223, Figure 3). However, there were no significant 
differences between individual groups.  
 
 
 
 
 
 
 
 
Figure 2.3 Total Sugar. Total sugar content (a summation 
of trehalose and glucose) of D. melanogaster fed a 0 
(control), 1, or 2 mg/mL GCBE diet for 5 days. Values are 
expressed as mean ± S.E.M. (n=4). GCBE, green coffee 
bean extract. 
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2.3.4 Lean Body Mass 
 Green coffee bean extract treatment did not change relative muscle content of flies, 
nor did relative muscle content vary between males and females (Figure 4).  
 
 
 
 
 
 
 
 
 
Figure 2.4 Lean Body Mass. Relative muscle content in D. 
melanogaster fed a 0 (control), 1, or 2 mg/mL GCBE diet for 5 
days. After treatment period, thorax weight was standardized 
by body weight and measured. Values are expressed as mean ± 
S.E.M. (n=6). GCBE, green coffee bean extract. 
20 
 
2.3.5 Food Intake 
There were significant differences in food intake by sex (P<0.0001) and GCBE 
treatment (P=0.0137) without significant interactions of sex and diet (Fig. 5). Female flies 
consumed more food than males, which is consistent with their larger body size and greater 
fat stores. Flies on the 2 mg/mL GCBE diet consumed 8% less food than control groups.  
 
 
 
 
 
 
 
 
Figure 2.5 Food Intake. Food intake of D. melanogaster fed a 
0 (control), or 2 mg diet for 5 days. Values are expressed as 
mean ± S.E.M. (n=4). n.s.: not significant. 
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2.3.6 Locomotor Activity 
Figure 6 depicts the total movement count of flies in a 24-hour period and a 
movement count over a 24-hour period in 30-minute increments. Flies, like other crepuscular 
insects, are primarily active at dawn and dusk (Ferguson et al., 2015) and in this experiment, 
strong peaks of activity were seen when daylight hours began. The total locomotor activities 
of flies were not different by sex or diet.  
 
Figure 2.6 Locomotor Activity. Locomotor activity and circadian rhythms of 
D. melanogaster reared 12:12 light/dark cycle at 25°C with diets containing 0 
(Control), 1, or 2 mg/mL GCBE. The locomotor activity of each individual fly 
for 24 h was presented as a 24-hour summation (locomotor activity) and in 30-
minute intervals (circadian). Values are expressed as mean ± S.E.M. (n=9-10). 
GCBE, green coffee bean extract. 
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2.3.7 PCR 
Akh is the human homolog of glucagon. There was a sex dependent effect on 
expression of Akh (P<0.0001) without effects from diet or sex-diet interaction (Fig. 7a). 
Males had an over 5.5-fold increase in expression compared to female flies.  
Srebp is a homolog of human sterol regulatory element-binding protein, a key 
regulator in lipogenesis. Echs-1 encodes for enoyl-CoA hydratase, which functions in the 
second step of mitochondrial fatty acid beta-oxidation. Bmm is a homolog of human 
adipocyte triglyceride lipase, which is a key regulator in lipolysis. Foxo is a transcription 
factor involved in insulin signaling. Its activation can also inhibit growth in response to 
cellular stresses. Whd encodes carnitine palmitoyltransferase I (CPT I), an enzyme required 
for the import of long-chain fatty acids into the mitochondria for beta-oxidation. There were 
no effects from sex, diet, or sex-diet interaction for srebp, echs-1, bmm, foxo, or whd (Fig. 
7b-f). 
Srl is homolog of peroxisome proliferator-activated receptor gamma coactivator-1 
alpha (PGC1α), a key regulator in energy homeostasis and mitochondrial biogenesis. There 
was a sex dependent effect on expression (P<0.0001) without effects from diet or sex-diet 
interaction (Fig. 7g). Females showed 4.6 times greater expression srl than male flies.  
Lsd-2 prevents the mobilization of lipid stores and is a regulator of lipid storage 
amount and energy homeostasis. There was a sex dependent effect on expression (P<0.0001) 
without effects from diet or sex-diet interaction (Fig. 7h). Males showed 85.3% greater 
expression of Lsd-2 compared to female flies. 
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Figure 2.7 Summary of PCR Results. Expression levels of adipokinetic hormone (akh, a), 
sterol regulatory element-binding protein (srebp, b), enoyl-CoA hydratase short chain 1 
(echs-1, c), brummer (bmm, d), forkhead box sub-group O (foxo, e), withered (whd, f), 
spargel (srl, g), and lipid storage droplet 2 (lsd-2, h) in D. melanogaster. Gene expression 
was determined using whole fly homogenates from flies fed with 0 (Control), 1, or 2 mg 
expressed /mL GCBE. Data are as the mean ± S.E.M. (n=4). P-value of the gene expressions 
are shown in the table. GCBE, green coffee bean extract. 
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2.3.7 The role of Chlorogenic Acid in GCBE 
In a comparison of flies fed an equivalent dose of CGA and GCBE, there was a 
significant difference in triglyceride levels based on sex (P<0.0001) and diet (P=0.0103) 
without sex-diet interaction (Figure 8). Flies treated with GCBE groups showed significant 
decrease from control (P=0.0080). Flies treated with chlorogenic acid did not have 
significant differences compared to the control or GCBE group.  
 
 
 
 
 
 
Figure 2.8 Fat Content. Triglyceride content of D. 
melanogaster fed a 0 (control), 0.5, or 1 mg/mL CGA diet 
for 5 days. Values are expressed as mean ± S.E.M. (n=6). 
TG, triglyceride; CGA, chlorogenic acid; GCBE, green 
coffee bean extract. 
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2.4 Discussion 
 This study shows that treatment with GCBE decreases fat accumulation in 
Drosophila without changes in lean body mass or glucose. The current results show that 
effects of GCBE on fat reduction were sex independent. This is the first investigation to 
report GCBE reduced fat accumulation, in part through a reduction of food intake in 
Drosophila melanogaster. However, additional research would be needed to clearly elucidate 
the mechanism of GCBE on body fat reduction.  
Previous studies of GCBE in rodent models suggest a wide variety of pathways that 
are involved in its metabolic effects. GCBE reduced body weight, visceral fat accumulation, 
insulin resistance, and altered lipid profiles by modulating genes related to fatty acid 
oxidation, energy homeostasis, adipocyte differentiation, and glucose metabolism (Choi et 
al., 2016; Li Kwok Cheong et al., 2014; Shimoda et al., 2006). This study did not identify 
differences in whole-body expression of genes involved in lipogenesis, fatty acid oxidation, 
energy homeostasis, or glucose regulation. However, whole-body analysis may have 
obscured the results. Previous work has shown that there are tissue specific differences in 
gene expression in flies (Girardot et al., 2006). It may be useful to study gene expression in 
different tissues, like the thorax and fat body of the abdomen to get a clearer view of changes 
in gene expression. 
This study identified decreased food intake by GCBE as a mechanism that 
contributed to decreased fat in male and female flies. GCBE could have reduced feeding due 
to its sensory properties. The major flavors associated with polyphenolic compounds, like 
CGA found in GCBE, are bitter and astringent (Cheynier, 2005), which may be detectable to 
flies. Fruit flies have the ability to perceive bitter substances through expression of gustatory 
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receptor (Gr) genes (Weiss et al., 2011) and will show avoidance behaviors toward foods 
containing bitter substances (French et al., 2015). Therefore, it is possible that flies in this 
study ate less food simply out of avoidance of GCBE. There was no sex-diet interaction of 
GCBE on food intake, even though females are typically more sensitive to bitter compounds 
and show decreased consumption of food containing polyphenols when males show no 
avoidance (P. B. Chen et al., 2019; Lacaille et al., 2009). This may be caused by sex-based 
differences in odorant-binding proteins in Drosophila (Swarup et al., 2014). One group found 
that flies entirely did not avoid consuming polyphenolic compounds from tea (Kayashima et 
al., 2015) and another found that flies can detect and are attracted to hydroxycinnamic acids 
in their diet (Dweck et al., 2015). Thus, there may be other factors besides taste perception 
that are responsible for GCBE causing a decrease in food intake. Further study into the 
effects of GCBE on food intake in Drosophila may be needed to determine the cause behind 
this response. 
 Factors like the endogenous circadian clock, courtship, and stress behaviors can affect 
locomotor activity in flies (Manenti et al., 2015). GCBE did not change locomotor activity 
even though caffeine is expected to increase locomotion. In another study on Drosophila, 
flies showed 25% increase in locomotion with 0.01% caffeine treatment. However, it’s likely 
that the dosage of caffeine in this study, about 0.004%, was not significant enough to cause a 
physiological change.  
In this study, no significant differences in lean body mass or total sugar were found 
between treatments. Sugars circulate in the Drosophila mainly as trehalose with glycogen as 
the main storage form (Yamada et al., 2018). Trehalose regulation in flies is a contentious 
topic as there is doubt whether flies hormonally regulate circulating sugars in the body, given 
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that levels of circulating sugar tend to reflect dietary sugar and metabolic activity (Graham & 
Pick, 2017). This is supported by the fact that flies require rapid mobilization of energy to 
power flight (Candy et al., 1997). Therefore, high variation in total sugar between samples 
may be caused by natural variance in sugar based on diet and metabolism. Further studies 
should be conducted to evaluate GCBE regulation of sugars in Drosophila.  
 CGA is the main polyphenolic compound present in GCBE, and several studies have 
shown its efficacy in reducing body weight and TG, improving lipid profiles, and moderating 
glucose and insulin (Bhandarkar et al., 2019; Cho et al., 2010; Farias-Pereira et al., 2018; Y. 
Huang et al., 2019; Ma et al., 2015; Ong et al., 2012; Sudeep et al., 2016). Some studies 
reported that CGA was able to reduce physiological factors like hepatic inflammation and 
cardiovascular indicators, but not body weight or fat in the models (Nishitsuji et al., 2018; 
Panchal et al., 2012). In our study, we found that the 5-CQA isomer of CGA had no effect on 
TG, suggesting that in flies, this may not be the main active compound in GCBE, or that it 
works in concert with other compounds found in GCBE. The bioavailability of polyphenols 
is highly variable, and its presence in a food or as an isolated compound can affect its 
absorption (Manach et al., 2004). It may be useful to assess the absorption of CGA as 
isolated 5-CQA compared to absorption through GCBE diet before further probing the 
effects of CGA in fruit flies.  
 Previous studies evaluating the effects of GCBE on metabolism used dosages of 
0.5%-1% diet (Farias-Pereira et al., 2018; Li Kwok Cheong et al., 2014; Shimoda et al., 
2006), 2-5 times higher than the dosage used in this study. In clinical trials with overweight 
subjects, patients used 180-200 mg daily (Onakpoya et al., 2011). There is currently no 
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knowledge on the relationship of GCBE dosage, oral bioavailability, or metabolism by 
microbiomes and biological systems in flies and humans, which is a limitation of this study. 
 
2.5 Conclusion 
 The current study investigated the effects of GCBE on metabolism in the model 
organism, Drosophila melanogaster. GCBE reduced body weight and fat accumulation but 
did not alter total body sugar or relative lean body mass. Though investigation into locomotor 
activity or gene expression did not show any changes from GCBE supplementation, the study 
identified reduced food intake as a mechanism for GCBE’s effects. Future investigation into 
the effects of GCBE should conducted to further elucidate its mechanism. This study 
provides a foundational basis for understanding of the effects of GCBE in Drosophila 
melanogaster. Overall, this can contribute to the body of knowledge on the use of phenolic 
compounds as anti-obesity nutraceuticals.  
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CHAPTER 3 
FUTURE DIRECTION 
 This study provides an introduction to the potential metabolic effects of GCBE in 
Drosophila melanogaster. With reduced body weight, fat accumulation, and food intake, 
there’s evidence that GCBE regulates metabolism in flies. However, no conclusive results 
were found regarding changes in total body sugar, locomotor activity, or gene expression of 
the chosen targets. In addition, CGA, the main polyphenolic compound in GCBE, did not 
reduce fat accumulation in flies. Therefore, the underlying mechanism of GCBE’s metabolic 
effects still need to be further determined.  
 Though the gene targets chosen in this study were involved in several pathways 
involved in lipogenesis, fatty acid oxidation, energy metabolism, and insulin signaling, only 
8 genes were assessed. There are several other genes that are relevant to these pathways that 
could be determined. Previous literature has identified genes that showed changes in 
expression after oral administration of GCBE or CGA. Relevant genes that were not tested in 
this study include acetyl CoA carboxylase (Sudeep et al., 2016), adiponectin and leptin (Cho 
et al., 2010), AMP-activated protein kinase, and other downstream targets (Ong et al., 2013). 
In addition, further literature could be conducted on metabolic regulation by other 
polyphenolic compounds to identify more potential gene targets. 
 In this study, RNA was extracted from whole body samples of flies. However, 
analyzing separate body parts of the flies, like the thorax or abdomen may provide useful 
results. Different body parts contain different tissues which may have different responses 
after treatment with GCBE. For example, the fat body contains most of the adipose tissue in 
the body. In other animal models, adipose tissue can have different expression from other 
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tissues. So, assessing the expression of genes related to energy metabolism specifically in the 
fat body could reveal more information on GCBE’s potential pathways of action.  
 A goal for the future of this project is to identify the compounds in GCBE that are 
responsible for its metabolic effects in flies. In this study, CGA had no significant effect on 
fat accumulation compared to control groups. This suggests that there may be other 
compounds in GCBE with bioactive effects. A series of experiments using analytical tools 
could be used to further investigate. First, the GCBE could be run through a high-
performance liquid chromatography (HPLC) column to identify other potential bioactive 
compounds. Then, flies could be treated with GCBE and isolated compounds, including 
CGA. The fly samples could be analyzed using HPLC to identify which compounds were 
absorbed. It is possible that isolated compounds, like the CGA (5-CQA) used in this study, 
may not have the same bioactivity as in a whole source like GCBE. Also, the compounds in 
GCBE may have synergistic effects when ingested together. Isolated compounds could be 
individually administered to flies and the samples could be compared with flies fed a mixture 
of compounds to assess whether certain compounds in GCBE can exert effects 
synergistically. This could be the beginnings of an investigation into the source of GCBE’s 
metabolic effects. 
 Overall, the study of GCBE in Drosophila can contribute to the overall knowledge of 
the mechanism and action of GCBE as a metabolic regulator for its use as an anti-obesity 
agent. Understanding its role in flies can provide insight into its actions in mammals and 
eventually, humans.  
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